In a cancer context, silencing of syndecan-4 expression was shown to exhibit an antitumoral effect on human papillary thyroid carcinoma cells by affecting apoptosis and epithelial-to-mesenchymal transition via the Wnt/beta-catenin pathway [23]. The gene discussed is CTNNB1; the disease is differentiated thyroid carcinoma.